Focus Stocks
Amgen Is Near a Key Resistance Area
Published on Monday, 11 February 2013 07:20 Written by TradersHuddle Wire
New York, February 11th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) are trading very close to calculated resistance at $87.47. The stock ended the trading session at just $86.77, which is near levels that make it difficult to buy or start a position.
Amgen Inc. (NASDAQ:AMGN) develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The company concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
Amgen's stock range is defined by its calculated support defined at $81.56 and by the resistance level at $87.47; the stock is clearly over-extended from support, making it harder for participants to establish fresh longs.
Traders don't have a clear entry point for Amgen. However, as the stock pulls back towards $81.56 it will definitely provide a reference point to establish a trade. On the other hand, if the stock breaks above its resistance level at $87.47 then traders will get an opportunity to enter the stock as it moves to a higher range.
Related Articles
- Trading the Setup In Amgen
- NASDAQ 100 Round Up - Flat: FSLR, CTRP, BIDU
- Reference Points for Amgen
- How to Play the Building Momentum in Amgen
- Trading Idea: Is Amgen close to Support?
- Amgen Is Close to the 50 Day Moving Average
- Amgen Is Close to its 50 Day Moving Average
- Amgen is Near a Key Support Area
- Is Amgen Close to Support?
- Reference Points for Amgen
Related Partner Headlines
- Cramer's Top Stock Picks: AMGN, HPY, but Avoid JCP - TheStreet.com
- Amgen Stock To Go Ex-dividend Tomorrow (AMGN) - TheStreet.com
- Amgen Inc (AMGN): Today's Featured Drugs Winner - TheStreet.com
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) - TheStreet.com
- Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial Did Not Meet Primary Endpoint - Benzinga
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) - TheStreet.com
- UPDATE: Oppenheimer Raises PT to $89 on Amgen - Benzinga
- UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Amgen - Benzinga
- Amgen's Third Quarter Earnings Report - Investopedia
- Analysts' Actions: CAT AMGN DNKN BTU COF - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,307.17 Trade time:4:44PM EDT Value change:▼80.41 (-0.52%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,655.35 Trade time:4:43PM EDT Value change:▼13.81 (-0.83%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,463.30 Trade time:5:15PM EDT Value change:0.00 (0.00%)In The Wires
-
GeckoSystems, an AI Mobile Robot Co., Signs $5M Joint Venture Contract -
PantoneLIVE Puts P&G Iconic Brand Colors in the Cloud -
Uganda Selects IBM and Waterfund to Benchmark Water Infrastructure -
Mattress Comparison Overview Released by The Sleepy Shopper; Compares Top Types and Brands -
Big Data & Predictive Analytics Please Meet the Performing Arts -
SunPower Announces Pricing of $300 Million Aggregate Principal Amount of its 0.75% Senior Convertible Debentures due 2018 -
The Coffee World Just Got A Little More Exciting -
eMazzanti Article Showcases Windows 8 Touch Technology








